News & Updates
Showing Multidisciplinary articles
Showing
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
A recent study has found no amino acid substitutions associated with reduced sensitivity to bulevirtide (BLV) monotherapy, a hepatitis D/B virus (HDV/HBV) entry inhibitor, at baseline or week 24 in patients with virologic breakthrough after BLV treatment.
SHBG levels inversely linked to hypertension in middle-aged adults
Levels of sex hormone-binding globulin (SHBG) show an inverse relationship with the development of hypertension and change in blood pressure (BP) levels, independent of major risk factors, according to a community-based study.
Which factors predict sustained RA remission with MTX or ETN monotherapy?
Following the switch from combination therapy to monotherapy, rheumatoid arthritis (RA) patients with overall lower disease activity (LDA) have higher odds of achieving and remaining in Simplified Disease Activity Index (SDAI) remission/LDA, suggests a study.
VELO supports liquid biopsy-guided anti-EGFR rechallenge therapy in mCRC
In the phase II VELO trial, third-line (3L) treatment with the anti-EGFR* monoclonal antibody (mAb) panitumumab and standard of care (SoC) improved progression-free survival (PFS) in patients with refractory RAS wild-type metastatic colorectal cancer (WT mCRC).